tadalafil has been researched along with Carcinoma, Papillary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bulotta, S; Celano, M; Damante, G; De Rose, RF; Di Gioia, CR; Durante, C; Filetti, S; Giacomelli, L; Maggisano, V; Pecce, V; Rosignolo, F; Russo, D; Sponziello, M; Verrienti, A | 1 |
1 other study(ies) available for tadalafil and Carcinoma, Papillary
| Article | Year |
|---|---|
PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclic Nucleotide Phosphodiesterases, Type 5; Female; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Proto-Oncogene Proteins B-raf; Sildenafil Citrate; Tadalafil; Thyroid Cancer, Papillary; Thyroid Neoplasms; Young Adult | 2015 |